The future of clinical research starts now
High-density data that drives clinical insights, speed and scalability, and scientific confidence.
Contact usProlaio believes
Meaningful data transforms the pace of drug development and patient outcomes
Our clinical intelligence platform with integrated medical insights and data analytics is designed to improve the efficiency and quality and increase the probability of success of cardiovascular clinical development.
↘ Longitudinal data collection delivered in a unified system
↘ Real-world data at scale captures daily life rather than singular snapshots
↘ Near real-time visibility provides timely and more granular insight
↘ Reduced patient burden by eliminating unnecessary travel
↘ Rapid, personalized signal detection for faster decision making
Unmatched experience
Prolaio's established regulatory and clinical foundation allows for confidence in data quality, reproducibility and regulatory rigor.
4M+
Hours of on-body patient data
20
Issued patents
7
FDA-cleared algorithms
26+
Countries served
40+
Proven algorithms
30+
Years of experience in machine learning
Why Prolaio?
Real-world data at scale
Prolaio enables continuous, remote measurement of vital signs and cardiac parameters in real-world settings throughout the entire clinical trial interval, rather than relying solely on periodic, scheduled clinic-based assessments.
Using clinical grade sensors worn by participants, Prolaio captures physiologic data during daily life, including pulse, respiration, activity and electrocardiogram.
We believe this real world, continuous data collection provides a more accurate view of physiologic variability while reducing patient and site burden, minimizing data gaps and improving visibility into treatment effects between clinic visits.
Our recent 510(k) clearance
eVO2peak
CPET-level cardiopulmonary insight—without the stress test.
eVO2peak is an accurate, reliable estimate of peak VO₂
CPET provides valuable information, but has some notable limitations, including:
↘ Need specialized equipment
↘ Sophisticated testing protocols
↘ Trained technicians
↘ Cardiac patients must complete a strenuous exercise test for valid results
eVO2peak addresses these limitations and can be administered remotely while patients carry out
normal daily activities.
Instead of a small number of CPET over the course of
a study, eVO2peak can be performed several times
over the same interval, improving endpoint sensitivity
without additional patient burden.
How Prolaio helps accelerate clinical research
Prolaio is positioned to shape and enable the design, execution and optimization of modern clinical development for precision cardiology.
Eligible patient identification
Quickly discover and enroll qualified candidates to help improve adherence and reduce dropout rates.
High‑density data insights
Achieve deeper, more comprehensive insights that help derisk resource allocation, reduce overall trial costs, and speed up clinical decision making.
Reduced variability & spot‑checking errors
Leverage near-real-time, intra-patient comparisons to avoid overlooking true differences and enable more detailed, informed statistical analyses.
Improved operational efficiency
A single strategic partner focused on providing clinical insights vs another “data dump” solution helps to simplify workflows and lower administrative overhead.
Early indicators of success
Access interim biomarker data to evaluate progress, pivot quickly if needed, and increase confidence that your trial is on the right track.